📚 Lecture Overview
This lecture covers hyperuricemia and gout, detailing their definitions, causes, clinical presentations, and management strategies. Understanding these concepts is vital because gout is a common and treatable metabolic disorder linked to purine metabolism and systemic complications.
🎯 Key Concepts & Definitions
- Hyperuricemia: Plasma uric acid levels greater than 7 mg/dL in males and greater than 6 mg/dL in females; the hallmark of gout.
- Gout: A heterogeneous group of congenital and acquired disorders characterized by chronic hyperuricemia and urate crystal deposition in tissues.
- Podagra: Acute gouty arthritis specifically affecting the first metatarsophalangeal joint (1st MTPJ), seen in 50% of initial attacks.
- Tophi: Painless white-yellowish deposits of monosodium urate crystals surrounded by mononuclear and giant multinucleated cells.
- Uricostatic Drugs: Medications like Allopurinol and Febuxostat that inhibit xanthine oxidase to reduce uric acid production.
- Uricosuric Drugs: Medications like Probenecid and Benzbromarone that enhance renal excretion of uric acid.
📖 Main Content
1. Definition and Causes of Hyperuricemia
- Uric acid is the end product of purine metabolism.
- Idiopathic causes: Result from increased urate production, decreased urinary clearance, or both.
- Secondary causes - Increased production:
- Congenital enzyme defects (e.g., Glucose 6-phosphatase deficiency).
- Increased nucleic acid turnover (e.g., hemolysis, leukemias, cytotoxic drugs, disseminated cancer, extensive psoriasis).
- Secondary causes - Decreased renal excretion:
- Impaired tubular excretion due to drugs (salicylates, L-dopa, thiazides).
- Metabolic acidosis, nephrogenic diabetes insipidus, and metabolic syndrome.
- Prevalence: Mainly affects adult men (peak incidence 40-45 years) and postmenopausal women. Only 20% of hyperuricemic persons ever develop clinical gout.
2. Clinical Presentations of Gout
Gout manifests through four primary clinical presentations:
- I. Acute Gouty Arthritis:
- 90% of first attacks are monoarticular.
- 50% occur in the 1st MTPJ (podagra).
- Overlying skin is typically dusky red with systemic signs of inflammation (fever, malaise, leukocytosis).
- Pathogenesis: Disruption of a subcortical tophus releasing urate crystals into the synovial fluid.
- Treatment of acute attacks: Joint rest, NSAIDs, Colchicine (blocks leukocyte-derived bioactive mediators like leukotriene B4), and steroids. (Note: Allopurinol is contraindicated during an acute attack).
- II. Tophaceous Gout:
- Tophi are painless white-yellowish deposits found on the external ear, fingertips, palms, soles, and around joints.
- Radiologically appear as radiolucent punched-out lesions or cortical erosions with characteristic overhanging margins.
- III. Gouty Nephropathy:
- Tophi formation in the renal medulla causes mild fibrosis and minimal tubular atrophy.
- GFR and essential renal function are generally maintained because the renal cortex is spared.
- IV. Uric Acid Urolithiasis:
- Incidence is 20% in gout patients (200 times more common than the general population).
- Stone formation depends on urinary uric acid concentration and urine acidity.
- Uric acid stones are radiolucent and only visible with contrast media.
3. Management of Intercritical and Chronic Gout
- Aim: Keep plasma uric acid < 6 mg/dL.
- General Measures:
- Weight reduction, moderate protein diet, avoid alcohol, revise drugs, and maintain high fluid intake (urine > 2000 mL/day).
- Pharmacological Treatment:
- Uricostatic drugs (Xanthine oxidase inhibitors):
- Allopurinol: Gold standard; inhibits conversion of xanthine and hypoxanthine to uric acid. Contraindicated for inducing acute attacks; dose must be reduced in renal impairment.
- Febuxostat: Safe with mild-to-moderate renal or hepatic impairment; great alternative for Allopurinol intolerance.
- Uricosuric drugs: Benzbromarone, Probenecid, Sulfinpyrazone, Lesinurad. (Note: Other drugs with uricosuric action include Losartan, Fenofibrate, and Amlodipine).
- Urine alkalinizing drugs: Sodium bicarbonate, sodium citrate, acetazolamide.
📊 Visual Learning
💡 Important Points to Remember
- Definition threshold: Plasma uric acid > 7 mg/dL in males, > 6 mg/dL in females.
- Asymptomatic ratio: Only 20% of hyperuricemic patients develop clinical gout.
- Most common initial site: 1st MTPJ (podagra) accounts for 50% of first attacks.
- Initial pathogenic event: Disruption of a subcortical tophus releasing urate crystals into synovial fluid.
- Acute attack trap: Never start Allopurinol during an acute attack because it can worsen or prolong the attack by mobilizing uric acid stores.
- Gold standard drug: Allopurinol is the primary uricostatic drug (inhibits xanthine oxidase).
- Renal alternative: Febuxostat is preferred in mild-to-moderate renal impairment without dose adjustment.
- Stone characteristic: Uric acid stones are radiolucent (invisible on plain X-rays, require contrast).
- Secondary causes: Driven by increased nucleic acid turnover (hemolysis, cancer, psoriasis) or decreased excretion (thiazides, salicylates, metabolic acidosis).
- Target plasma level: Maintain uric acid below 6 mg/dL in chronic management.
- Uricosuric bonus drugs: Losartan, Fenofibrate, and Amlodipine possess secondary uricosuric properties.
⚠️ Common Exam Questions
- MCQ Trap on Acute Treatment: Examiners will ask for the best drug to start in a patient currently suffering from acute gouty arthritis.
- The Trap: Listing Allopurinol as an option to lower uric acid immediately.
- The Correction: Allopurinol is contraindicated during an acute attack; use NSAIDs, colchicine, or steroids instead.
- Radiology Question: An examiner might show an X-ray of a joint with punched-out erosions and overhanging margins, asking for the diagnosis.
- The Answer: Tophaceous gout.
- Stone Imaging Question: "A patient with gout presents with renal colic, but the plain abdominal X-ray (KUB) shows no stones. Why?"
- The Answer: Uric acid stones are radiolucent and require contrast media or ultrasound to be visualized.
📝 Quick Review Checklist
I can define hyperuricemia and its gender-specific cutoffs
I understand the pathogenesis of acute gouty arthritis
I can list the four clinical presentations of gout
I know why Allopurinol is contraindicated during an acute attack
I can differentiate between uricostatic and uricosuric drugs
I understand the radiological features of tophaceous gout
I know the characteristics of uric acid urolithiasis